The CathHELIX Solution
™
Building on the principles of annuloplasty, smart engineering and design combine to create an advanced mitral regurgitation treatment option providing:
• Ease of implant placement and retention
• Reliable implant securement
• Efficient procedure time with concise learning curve
• Standard echo views supported by TEE
• Confidence in the result and in knowing future treatment options remain
CathHELIX provides the benefits of an annuloplasty – a proven, lasting treatment for mitral valve repair – while using a familiar transcatheter approach.
After reducing the annulus with the Mitral Annulus Reduction System (MARS), the unique self-securing CathHELIX ring is deployed, automatically securing itself in the atrial supra-annular groove and on the ventricular side in the sub-annular groove of the reduced annulus.
1
-
Baldus S, Doenst T, Pfister R, et al. Transcatheter repair versus mitral-valve surgery for secondary mitral regurgitation. N Engl J Med. DOI: 10.1056/NEJMoa2408739. nejmoa2408739_appendix.pdf
The FDA granted CathHELIX™ a
Breakthrough Device Designation
and has continued to closely collaborate with HVR Cardio
